Biggest Giants: Buy, Sell Guide for U.S. Oil Majors in 2026
As oil prices rebound in 2026, investors weigh the three biggest U.S. oil majors. This report outlines buy, sell or h...
This guide covers withdrawal-friendly total market ETFs and how to structure distributions to maximize cash flow while controlling taxes in retirement.
28,154 articlesAs oil prices rebound in 2026, investors weigh the three biggest U.S. oil majors. This report outlines buy, sell or h...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
May pending home sales showed a notable uptick despite higher borrowing costs. The NAR report shows gains across regi...
The Fed left its policy rate unchanged, but a veteran observer says the odds of a hike this year remain intact as War...
Berkshire Hathaway disclosed a new stake in Macy’s in its Q1 2026 13F, a small starter position that contrasts with p...
Two budding EV stars, Lucid and Rivian, are racing from zero to scale. This deep dive compares their paths, risks, an...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Stocks of Intel, AMD and Taiwan Semiconductor slid as Bank of America warned that bubble risk may be rising in the AI...
Famed investor Michael Burry reportedly tacks a bearish stance onto Micron Technology, signaling renewed caution for ...
A three-week ban on Anthropic's AI services by U.S. regulators ended, igniting a debate over whether the episode coul...
Trump appears set to scrap the memorandum of understanding with Iran, yet U.S. markets are largely muted as traders f...
Abbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...